Showing 43,981 - 44,000 results of 45,549 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 0.86s Refine Results
  1. 43981

    Table_2_Boundary-based registration improves sensitivity for detecting hypoperfusion in sporadic frontotemporal lobar degeneration.DOCX by Sylvia Mihailescu (19454665)

    Published 2024
    “…Arterial Spin Labeling (ASL) MRI is often acquired in the same session as a structural T1-weighted image (T1w), enabling detection of regional changes in cerebral blood flow (CBF). …”
  2. 43982

    Table_1_Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients.DOCX by Tong Li (206968)

    Published 2020
    “…Both Crohn's Disease Endoscopic Index of Severity (13.4 ± 4.92 vs. 6.12 ± 5.24, P < 0.001) and Rutgeerts scores (3.23 ± 0.73 vs. 1.77 ± 1.59, P = 0.003) were significantly decreased with the use of combination therapy. Adverse events occurred in 62 (50.8%) patients, but only 13 (10.7%) necessitated therapy discontinuation. …”
  3. 43983

    SPI under <i>K</i> different distance ranges. by Thao Vu (3363083)

    Published 2023
    “…<p><i>K</i> values were incremented from 25 to 100 in steps of 5. At each <i>K</i>, a sequence of distance breaks was generated by linearly decreasing from <i>d</i><sub><i>K</i></sub> to 0 on a log scale. …”
  4. 43984

    Figure 7 from KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma by Elisabet Figuerola-Bou (22618659)

    Published 2025
    “…<p>KDM6B KO decreases tumor growth. <b>A,</b> Colony formation assay of KDM6B KO cells (sgRNA#1 and sgRNA#2) compared with parental and sgCTRL A-673 cells. …”
  5. 43985

    Right Main Bronchus Transection After Blunt Thoracic Trauma by Ivan CH Siu (11978159)

    Published 2022
    “…<p>Tracheobronchial injury is a rare occurrence in people with blunt thoracic trauma, and it is associated with significant mortality (1). …”
  6. 43986

    Depletion of endogenous miR-BART9 suppresses the migration and invasiveness of EBV-positive NPC cells. by Chung-Yuan Hsu (528381)

    Published 2014
    “…<p>(A) LNA-modified anti-BART9 efficiently decreases the level of mature miR-BART9 in EBV-positive HK1-EBV and C666-1 cells. …”
  7. 43987

    RITA leads to CHK2 phosphorylation and SIRT1 inhibition in head and neck cancer cell lines. by Hui-Ching Chuang (614643)

    Published 2014
    “…Data are expressed as means ± S.E from three experiments.</p>…”
  8. 43988

    Increasing network size does not guarantee convergence to a balanced state. by Pierre Ekelmans (15470955)

    Published 2023
    “…The inset shows the excitatory rate for network sizes from <i>N</i> = 4 × 10<sup>3</sup> (blue) to <i>N</i> = 5 × 10<sup>5</sup> (red), in steps of ×10<sup>0.1</sup> obtained using the SSN. …”
  9. 43989

    Stit is required for optimal growth of the wing epithelium. by Fergal O'Farrell (435865)

    Published 2013
    “…The number of discs examined (<i>n</i>) is indicated. Scale bar, 50 µm. (H) 10 min of EdU incorporation did not show a compartment-specific change in cells entering into S-phase in <i>ap</i>><i>Stit<sup>KD</sup></i> discs versus <i>ap>GFP</i> control discs. …”
  10. 43990

    Notch activation drives apical constriction and epithelial fold. by Hui-Yu Ku (3185502)

    Published 2017
    “…(D) Proportions of the three cell populations in <i>hth</i>><i>N</i><sup><i>DN</i></sup> EAD. There is a reduction of cells with a decreasing apical area (red), and an increase of cells with a fluctuating apical area (blue). …”
  11. 43991

    Nutrition regulates <i>gbp1</i> and <i>gbp2</i> expression via TOR signaling in the fat body. by Takashi Koyama (417981)

    Published 2016
    “…We used the fat bodies from five larvae for each sample and five biologically independent samples for each condition. …”
  12. 43992

    First year physical activity findings from turn up the HEAT (Healthy Eating and Activity Time) in summer day camps by R. Glenn Weaver (3873328)

    Published 2017
    “…Boys in comparison SDCs increased by +1.6% (81–83%) and girls decreased by -5.5% (76–71%). Process data indicated intervention SDCs successfully extended and enhanced PA opportunities, but were unable to expand PA opportunities, compared to control SDCs.…”
  13. 43993

    Computational optimization of the circuits for specific functions further reveals general design principles. by Xiaojing Yang (154840)

    Published 2013
    “…(C) <i>In silico</i> evolution to optimize the catalytic efficiencies of the kinases for a desired function in discrete steps of mutation and selection (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001673#pbio.1001673.s005" target="_blank">Figure S5A</a> for a detailed illustration). …”
  14. 43994

    Muscular and metabolic responses to different Nordic walking techniques, when style matters by Barbara Pellegrini (801238)

    Published 2018
    “…Ten NW instructors volunteered to walk on a treadmill at 5.5 km•h<sup>-1</sup> in five conditions: walking (W), Nordic walking (NW), NW with a weak poling action (NW<sub>weak</sub>), with straight-upper limbs moving the shoulders (NW<sub>shoulder</sub>) and with elbow flexion-extension pattern and shoulder freezed (NW<sub>elbow</sub>). …”
  15. 43995

    DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Con... by Melanie Thompson (207727)

    Published 2016
    “…<div><p>GV-TH-01, a Phase 1 open-label trial of a DNA prime—Modified Vaccinia Ankara (MVA) boost vaccine (GOVX-B11), was undertaken in HIV infected participants on antiretroviral treatment (ART) to evaluate safety and vaccine-elicited T cell responses, and explore the ability of elicited CD8+ T cells to control viral rebound during analytical treatment interruption (TI). …”
  16. 43996

    datasheet1_The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.pdf by Evelien Moorkens (4723848)

    Published 2021
    “…When reported, discounts/rebates on originator adalimumab after loss of exclusivity ranged from 0% to approximately 26% (Romania), 60% (Poland), 80% (Denmark, Italy, Norway), and 80–90% (Netherlands), leading to actual prices per pen or syringe between €412 (Finland) and €50 – €99 (Netherlands). To leverage competition following entry of biosimilar adalimumab, only a few countries adopted measures specifically for adalimumab in addition to general policies regarding biosimilars. …”
  17. 43997

    Computational Analysis of Target Site Occurrence by Julius Brennecke (2231)

    Published 2013
    “…<div><p>(A) Genome-wide occurrence of conserved 5′ seed matches. …”
  18. 43998

    Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings by Monika Madan (95727)

    Published 2008
    “…</p><h3>Methods and Results</h3><p>To explore the role of TLR2 in inflammation- and infection-associated atherosclerosis, 10 week-old ApoE<sup>+/−</sup>-TLR2<sup>+/+</sup>, ApoE<sup>+/−</sup>-TLR2<sup>+/−</sup> and ApoE<sup>+/−</sup>-TLR2<sup>−/−</sup> mice were fed either a high fat diet or a regular chow diet. All mice were inoculated intravenously, once per week for 24 consecutive weeks, with 50 µl live <em>Porphyromonas gingivalis</em> (<em>P.g</em>) (10<sup>7</sup> CFU) or vehicle (normal saline). …”
  19. 43999

    Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound by Urati Anuradha (20306190)

    Published 2024
    “…<p><b>Aim:</b> To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils.…”
  20. 44000

    Image_8_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”